Chlorinated mandelamidines
    1.
    发明授权
    Chlorinated mandelamidines 失效
    氯化扁桃酰脒

    公开(公告)号:US3899533A

    公开(公告)日:1975-08-12

    申请号:US41777273

    申请日:1973-11-21

    Applicant: ORSYMONDE

    Inventor: SOUCHARD MADDY

    CPC classification number: C07D239/06 C07C259/14 C07D233/22

    Abstract: New chlorinated derivatives of mandelamidine and acid addition salts thereof are produced by reacting a mandeliminoalkyl ether of the formula

    in which A is alkyl lower alkyl group, preferably C1-C2, and X, Y, Z represent H or Cl, one at least of the X, Y and Z being a chlorine atom, or one of the acid addition salts of the said mandeliminoalkyl ether, preferably the hydrochloride, with an amine of the formula

    Abstract translation: 通过使式NH CHOH-C ANGLE OA的烷基亚氨基烷基醚(其中A是烷基低级烷基,优选C 1 -C 2)与X,Y,Z表示H或Cl 至少X,Y和Z中的至少一个为氯原子,或所述扁桃酰烷基醚,优选盐酸盐的酸加成盐之一与式HNR1R'2的胺,其中R1如上定义, R'2表示氢原子,C1-C5低级烷基,NH2基,OH基,R'2可以是(CH2)nNH2基,其中n是2的整数 或当R1 = H时为3,如果需要,当R2不同于OH时,由此获得的产物进行用于引入基团R =酰基的酯化反应。 这些新衍生物特别适用于治疗高血压。

Patent Agency Ranking